gliconorm

pylera
dibase

Gliconorm™ is a film-coated, divisible tablet which contains a fixed dose of glibenclamide (5 mg) and metformin (500 mg).

Name  Gliconorm
 Description  Gliconorm™ is a second line therapy to treat non-insulin dependent diabetes mellitus (NIDDM). This fixed dose in one tablet provides convenience for patients and helps increase patient compliance.
 Active substance  Glibenclamide, Metformin.
 Indication  Gliconorm™ is a second line therapy to treat non-insulin dependent diabetes mellitus (NIDDM) that cannot be satisfactorily controlled with diet alone, diet plus a sulfonylurea, or diet plus metformin.
 Strengths  Glibenclamide 5mg + Metformin 500mg.
Regulatory Status Approved in Italy, last revised: Nov 2007
Approved in Bahrain – 14 Dec 2011
Under registration – Iraq and Kuwait
Business Partner ABIOGEN
pylera
dibase